[HTML][HTML] Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron

F Kirca, S Aydoğan, A Gözalan… - Revista da Associação …, 2022 - SciELO Brasil
… CT scan was performed for patients with suspected wild-type SARS-CoV-2 in our hospital. …
patients with wild-type SARS-CoV-2 diagnosed by rRT-PCR and simultaneous chest CT. …

Differences in clinical characteristics between delta variant and wild-type SARS-CoV-2 infected patients

Z Hu, X Huang, J Zhang, S Fu, D Ding, Z Tao - Frontiers in medicine, 2022 - frontiersin.org
… against wild-type SARS-CoV-2 (53). For BNT162b2 (an mRNA vaccine) and ChAdOx1 nCoV
COVID-19 demonstrated less sensitivities than that of other SARS-CoV-2 strain (13). On top …

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

KR Bewley, NS Coombes, L Gagnon, L McInroy… - Nature protocols, 2021 - nature.com
… use of wild-type virus. This ensures that all severe acute respiratory syndrome coronavirus 2
… These assays have been used in the development and licensure of the ChAdOx1 nCoV-19 (…

Infection of wild-type mice by SARS-CoV-2 B. 1.351 variant indicates a possible novel cross-species transmission route

T Pan, R Chen, X He, Y Yuan, X Deng, R Li… - Signal transduction and …, 2021 - nature.com
… Genetic modifications of SARS-CoV-2 or mice enable the mice susceptible to viral infection.
… contact transmission of SARS-CoV-2 variant B.1.351 in wild-type mice. The SARS-CoV-2 (B.…

An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron

BX Quan, H Shuai, AJ Xia, Y Hou, R Zeng, XL Liu… - Nature …, 2022 - nature.com
SARS-CoV-2 M pro inhibitor with potent in vivo antiviral activity against wild-type (WT)
and emerging variants of SARS-CoV… against WT SARS-CoV-2 and emerging SARS-CoV-2 …

Association of omicron vs wild-type SARS-CoV-2 variants with hospital-onset SARS-CoV-2 infections in a US regional hospital system

M Klompas, MC Pandolfi, AB Nisar, MA Baker, C Rhee - JAMA, 2022 - jamanetwork.com
… We retrospectively identified all SARS-CoV-2 cases … We calculated monthly incidence rates
for SARS-CoV-2 … given the incubation period of SARS-CoV-2 (wild-type median 5 days, Delta …

The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern

L Lin, Y Liu, X Tang, D He - Frontiers in public health, 2021 - frontiersin.org
… By comparing with the wild-type virus, in terms of the risk of hospitalization, ICU admission,
… , and all SARS-COV-2 VOCs have a higher risk of disease severity than the wild-type virus. …

Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site

J Lee, LJ Worrall, M Vuckovic, FI Rosell… - Nature …, 2020 - nature.com
… To that end, in this paper, we present the structure, at 1.95 Å resolution, of the wild-type
acyl-enzyme intermediate of SARS-CoV-2 M pro covalently bound to its natural autocatalytic …

Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus

F Amanat, S Strohmeier, PS Meade… - PLoS …, 2021 - journals.plos.org
wild-type SARS-CoV-2 and from variants B.1.1.7, B.1.351, and P.1 for their immunogenicity
and protective effect in vivo against challenge with wild-type SARS-CoVwild-type SARS-CoV-…

In-flight transmission of wild-type SARS-CoV-2 and the outbreak potential of imported clusters of COVID-19: a review of published evidence

D Kelly, N Bambury, M Boland - Globalization and health, 2021 - Springer
… in-flight transmission of wild type SARS-CoV-2 during 2020, … emergence of new mutations
causing SARS-CoV-2 variants of … on in-flight transmission of wild-type SARS-CoV-2 is limited, …